AIRBORNE

AIRBORNE was reported 674 times

AIRBORNE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATHETER SITE PUSTULE 1 0.0909
1 NASAL IRRIGATION 1 0.0625
2 PRIMARY COUGH HEADACHE 1 0.0588
3 DENTAL ATTRITION 1 0.0400
4 URETHRAL CYST 1 0.0303
5 GLIONEURONAL TUMOUR 1 0.0185
6 TUMOUR OBSTRUCTION 1 0.0115
7 HEPATIC ARTERY ANEURYSM 1 0.0104
8 INTESTINAL MUCOSAL ATROPHY 1 0.0100
9 SNAKE BITE 1 0.0100
10 INFLAMMATORY MARKER DECREASED 1 0.0095
11 INTERVERTEBRAL DISC ANNULAR TEAR 1 0.0094
12 ANORECTAL POLYP 1 0.0093
13 ECZEMA WEEPING 1 0.0076
14 MYELOMA CAST NEPHROPATHY 1 0.0070
15 DEVICE FASTENER ISSUE 1 0.0068
16 IMMUNOLOGY TEST ABNORMAL 1 0.0064
17 PROCEDURAL DIZZINESS 2 0.0062
18 BENIGN RENAL NEOPLASM 1 0.0058
19 CUTANEOUS CALCIFICATION 1 0.0055
20 SUPINE HYPERTENSION 1 0.0053
21 PARASITIC GASTROENTERITIS 1 0.0052
22 ADULT FAILURE TO THRIVE 1 0.0047
23 PRODUCT ADVERTISING ISSUE 1 0.0047
24 ADRENAL NEOPLASM 2 0.0043
25 OPHTHALMIC VEIN THROMBOSIS 1 0.0041
26 ADENOTONSILLECTOMY 1 0.0040
27 CENTRAL PAIN SYNDROME 1 0.0038
28 HEPATIC ARTERY THROMBOSIS 1 0.0034
29 RELAPSING MULTIPLE SCLEROSIS 1 0.0033
30 TUMOUR PERFORATION 1 0.0031
31 DEFECT CONDUCTION INTRAVENTRICULAR 1 0.0031
32 BENIGN NEOPLASM OF SKIN 1 0.0030
33 POST CONCUSSION SYNDROME 1 0.0029
34 LIGAMENT OPERATION 1 0.0029
35 MEDIAL TIBIAL STRESS SYNDROME 1 0.0029
36 OESOPHAGEAL INJURY 1 0.0026
37 NORMAL PRESSURE HYDROCEPHALUS 1 0.0024
38 PROCEDURAL HEADACHE 1 0.0024
39 INTESTINAL PROLAPSE 1 0.0024
40 VOLUME BLOOD DECREASED 1 0.0024
41 PERIORBITAL PAIN 2 0.0024
42 CATHETER SITE RASH 1 0.0022
43 HERNIA PAIN 1 0.0022
44 OESOPHAGEAL ADENOCARCINOMA 1 0.0021
45 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
46 DEPENDENCE ON OXYGEN THERAPY 1 0.0020
47 HYPERMOBILITY SYNDROME 1 0.0020
48 PYODERMA 1 0.0020
49 CAPILLARY FRAGILITY 1 0.0020
50 GASTROINTESTINAL FUNGAL INFECTION 1 0.0019
51 HYPERTROPHY 1 0.0018
52 TUMOUR RUPTURE 1 0.0018
53 SOFT TISSUE SWELLING 1 0.0018
54 URINARY TRACT INFECTION FUNGAL 1 0.0017
55 DEVICE MAINTENANCE ISSUE 1 0.0017
56 MEAN PLATELET VOLUME INCREASED 1 0.0017
57 BLOOD BILIRUBIN DECREASED 1 0.0016
58 VITAMIN D INCREASED 1 0.0016
59 POST PROCEDURAL SEPSIS 1 0.0015
60 OESOPHAGEAL DISCOMFORT 1 0.0013
61 DIZZINESS EXERTIONAL 1 0.0013
62 ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC 1 0.0013
63 BREAST FEEDING 1 0.0013
64 WOUND DRAINAGE 1 0.0013
65 VITAMIN B12 INCREASED 1 0.0013
66 OXYGEN CONSUMPTION INCREASED 3 0.0013
67 PROCEDURAL NAUSEA 1 0.0012
68 TONGUE ERYTHEMA 1 0.0012
69 SEPTIC EMBOLUS 1 0.0012
70 GASTRIC DILATATION 2 0.0012
71 INFUSION SITE OEDEMA 1 0.0012
72 EXPOSURE TO SARS-COV-2 2 0.0012
73 ENDOCRINE OPHTHALMOPATHY 1 0.0012
74 CYSTOCELE 1 0.0012
75 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
76 UPPER AIRWAY OBSTRUCTION 1 0.0011
77 FIBROMA 1 0.0011
78 WRIST SURGERY 1 0.0011
79 WRONG SCHEDULE 1 0.0010
80 INJECTION SITE SCAB 1 0.0010
81 ONCOLOGIC COMPLICATION 1 0.0010
82 ONYCHALGIA 1 0.0010
83 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
84 GASTRIC PH DECREASED 1 0.0010
85 CARPAL TUNNEL DECOMPRESSION 1 0.0009
86 NEUROMYOPATHY 1 0.0009
87 ALLERGY TO ANIMAL 1 0.0009
88 UTERINE PROLAPSE 1 0.0009
89 INFUSION SITE HAEMORRHAGE 3 0.0009
90 NASAL PRURITUS 1 0.0008
91 CALCIUM DEFICIENCY 1 0.0008
92 INTESTINAL MASS 1 0.0007
93 DRUG TOLERANCE DECREASED 2 0.0007
94 JOINT LOCK 2 0.0007
95 NEGATIVE THOUGHTS 2 0.0007
96 SLEEP PARALYSIS 1 0.0007
97 GENITAL PAIN 1 0.0007
98 EPICONDYLITIS 1 0.0007
99 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
100 INHIBITORY DRUG INTERACTION 1 0.0006
101 CYSTITIS INTERSTITIAL 1 0.0006
102 VULVOVAGINAL DRYNESS 2 0.0006
103 HEPATIC NEOPLASM 2 0.0006
104 OXYGEN THERAPY 1 0.0006
105 SKIN WOUND 1 0.0006
106 DEAFNESS BILATERAL 1 0.0006
107 ACUTE SINUSITIS 1 0.0006
108 KIDNEY FIBROSIS 1 0.0006
109 SPONDYLOLISTHESIS 1 0.0006
110 MENINGITIS CRYPTOCOCCAL 1 0.0006
111 FEAR OF DISEASE 1 0.0006
112 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
113 BODY TEMPERATURE ABNORMAL 1 0.0005
114 AURA 1 0.0005
115 IMPATIENCE 1 0.0005
116 NARCOLEPSY 1 0.0005
117 JOINT NOISE 1 0.0005
118 PROSTATOMEGALY 2 0.0005
119 JOINT CREPITATION 1 0.0005
120 FUNGAL SKIN INFECTION 2 0.0005
121 SEASONAL ALLERGY 7 0.0005
122 TRIGGER FINGER 2 0.0005
123 RENAL MASS 1 0.0005
124 BODY TEMPERATURE FLUCTUATION 1 0.0005
125 URINARY BLADDER HAEMORRHAGE 1 0.0005
126 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
127 NEUROGENIC BLADDER 1 0.0005
128 HORDEOLUM 2 0.0005
129 GASTROINTESTINAL ULCER 1 0.0005
130 CALCINOSIS 1 0.0004
131 BRAIN NEOPLASM MALIGNANT 2 0.0004
132 NERVE COMPRESSION 4 0.0004
133 REACTION TO EXCIPIENT 1 0.0004
134 INFUSION SITE INFECTION 1 0.0004
135 UTERINE DISORDER 1 0.0004
136 ROSACEA 2 0.0004
137 INGROWING NAIL 1 0.0004
138 VOLVULUS 1 0.0004
139 CARDIAC TAMPONADE 2 0.0004
140 URINE FLOW DECREASED 1 0.0004
141 LEARNING DISORDER 1 0.0004
142 UTERINE LEIOMYOMA 3 0.0004
143 DEVICE INFUSION ISSUE 1 0.0004
144 PLATELET DISORDER 1 0.0004
145 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
146 APHTHOUS ULCER 3 0.0004
147 POSTMENOPAUSAL HAEMORRHAGE 1 0.0004
148 URINE OUTPUT INCREASED 1 0.0004
149 WEIGHT BEARING DIFFICULTY 1 0.0004
150 ABDOMINAL RIGIDITY 1 0.0004
151 APPLICATION SITE HAEMORRHAGE 1 0.0004
152 ORAL FUNGAL INFECTION 1 0.0004
153 HYPERKERATOSIS 2 0.0004
154 ENDOTRACHEAL INTUBATION 1 0.0004
155 SINUS DISORDER 7 0.0004
156 HEART VALVE INCOMPETENCE 1 0.0003
157 RETINAL VEIN OCCLUSION 1 0.0003
158 DYSPNOEA AT REST 1 0.0003
159 TASTE DISORDER 7 0.0003
160 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
161 LUMBAR SPINAL STENOSIS 1 0.0003
162 NECK INJURY 1 0.0003
163 THORACIC VERTEBRAL FRACTURE 1 0.0003
164 DYSCHEZIA 1 0.0003
165 INFUSION SITE EXTRAVASATION 2 0.0003
166 ARTERIOSCLEROSIS 3 0.0003
167 INFUSION SITE PRURITUS 1 0.0003
168 ORTHOPNOEA 1 0.0003
169 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
170 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
171 FACET JOINT SYNDROME 1 0.0003
172 SUSPECTED COVID-19 1 0.0003
173 POST-TRAUMATIC STRESS DISORDER 2 0.0003
174 TONGUE ULCERATION 1 0.0003
175 EAR DISCOMFORT 3 0.0003
176 WOUND COMPLICATION 1 0.0003
177 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
178 LEFT VENTRICULAR FAILURE 1 0.0003
179 THERMAL BURN 2 0.0003
180 SKIN WEEPING 1 0.0003
181 SPONDYLITIS 1 0.0003
182 SNEEZING 6 0.0003
183 PAROSMIA 2 0.0003
184 SNORING 1 0.0003
185 PARANASAL SINUS HYPERSECRETION 1 0.0003
186 BOWEL MOVEMENT IRREGULARITY 2 0.0003
187 GINGIVAL DISORDER 1 0.0003
188 ORAL INFECTION 1 0.0003
189 WOUND SECRETION 1 0.0003
190 GASTROINTESTINAL INFLAMMATION 2 0.0003
191 MULTIPLE ALLERGIES 2 0.0003
192 OESOPHAGEAL PAIN 1 0.0003
193 DISEASE RECURRENCE 12 0.0003
194 GINGIVAL PAIN 2 0.0003
195 TRIGEMINAL NEURALGIA 1 0.0002
196 NOCTURIA 3 0.0002
197 SPINAL FUSION SURGERY 1 0.0002
198 POST PROCEDURAL INFECTION 2 0.0002
199 SPINAL STENOSIS 1 0.0002
200 AORTIC DISSECTION 1 0.0002
201 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
202 VIRAL INFECTION 8 0.0002
203 SELF-INJURIOUS IDEATION 1 0.0002
204 SLEEP TERROR 1 0.0002
205 TONGUE DISCOMFORT 1 0.0002
206 ABSCESS LIMB 1 0.0002
207 CARDIAC FAILURE CHRONIC 1 0.0002
208 RHINORRHOEA 15 0.0002
209 OCULAR ICTERUS 1 0.0002
210 CHAPPED LIPS 1 0.0002
211 DYSPHEMIA 1 0.0002
212 ONYCHOMYCOSIS 1 0.0002
213 GROIN PAIN 2 0.0002
214 PHYSICAL DISABILITY 1 0.0002
215 RHINITIS ALLERGIC 1 0.0002
216 SINUS CONGESTION 3 0.0002
217 URINARY TRACT DISORDER 1 0.0002
218 GASTROENTERITIS VIRAL 4 0.0002
219 SUSPECTED OFF LABEL USE 1 0.0002
220 NASAL CONGESTION 13 0.0002
221 DRUG EFFECT DELAYED 1 0.0002
222 URINE ABNORMALITY 1 0.0002
223 ABDOMINAL HERNIA 1 0.0002
224 PERIPHERAL COLDNESS 3 0.0002
225 SYNOVIAL CYST 1 0.0002
226 LOCALISED OEDEMA 1 0.0002
227 ORAL DISCOMFORT 3 0.0002
228 ARTHRITIS INFECTIVE 1 0.0002
229 PERFORMANCE STATUS DECREASED 1 0.0002
230 DIARRHOEA HAEMORRHAGIC 2 0.0002
231 ILLNESS 22 0.0002
232 YELLOW SKIN 1 0.0002
233 TIBIA FRACTURE 1 0.0002
234 DYSPNOEA EXERTIONAL 8 0.0002
235 SKIN ABRASION 1 0.0002
236 SPINAL DISORDER 2 0.0002
237 SPUTUM DISCOLOURED 2 0.0002
238 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
239 URINARY RETENTION 7 0.0002
240 ENDOMETRIOSIS 1 0.0002
241 SLEEP APNOEA SYNDROME 4 0.0002
242 PRODUCTIVE COUGH 10 0.0002
243 LIMB OPERATION 1 0.0002
244 PARAESTHESIA ORAL 3 0.0002
245 AFFECT LABILITY 2 0.0002
246 EAR PAIN 4 0.0002
247 FIBROMYALGIA 5 0.0002
248 VITAMIN D DEFICIENCY 2 0.0002
249 HORMONE LEVEL ABNORMAL 1 0.0002
250 ORAL HERPES 4 0.0002
251 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
252 APPLICATION SITE BURN 1 0.0002
253 SPRUE-LIKE ENTEROPATHY 1 0.0002
254 HYPERVOLAEMIA 1 0.0002
255 DYSGEUSIA 15 0.0002
256 AGEUSIA 5 0.0002
257 BRAIN INJURY 2 0.0002
258 DRUG TOLERANCE 1 0.0002
259 DRY THROAT 2 0.0002
260 HIP ARTHROPLASTY 3 0.0002
261 INITIAL INSOMNIA 2 0.0002
262 PRODUCT PREPARATION ERROR 4 0.0002
263 THYROID DISORDER 3 0.0002
264 TRISMUS 1 0.0002
265 FAILURE TO THRIVE 1 0.0002
266 VENTRICULAR EXTRASYSTOLES 2 0.0002
267 BRAIN FOG 3 0.0002
268 FOOD CRAVING 1 0.0002
269 FULL BLOOD COUNT ABNORMAL 2 0.0002
270 RESPIRATORY TRACT CONGESTION 3 0.0002
271 BODY HEIGHT DECREASED 2 0.0002
272 FOOD POISONING 1 0.0002
273 OVERWEIGHT 1 0.0002
274 BRUXISM 1 0.0002
275 GINGIVITIS 1 0.0002
276 DECREASED ACTIVITY 2 0.0002
277 HIP SURGERY 1 0.0002
278 FAECALOMA 1 0.0002
279 NONSPECIFIC REACTION 1 0.0002
280 ASTHENOPIA 1 0.0002
281 DEAFNESS UNILATERAL 1 0.0002
282 TOOTH FRACTURE 2 0.0002
283 FOOT DEFORMITY 2 0.0002
284 DRY EYE 9 0.0002
285 ORAL PAIN 4 0.0002
286 SKIN INFECTION 2 0.0002
287 OCULAR DISCOMFORT 2 0.0002
288 EYE INFECTION 2 0.0002
289 PERIORBITAL SWELLING 1 0.0002
290 GENERALISED ERYTHEMA 1 0.0002
291 DERMATITIS CONTACT 2 0.0002
292 MICTURITION URGENCY 2 0.0002
293 TINNITUS 8 0.0002
294 ENTEROCOLITIS 1 0.0002
295 PERICARDIAL EFFUSION 4 0.0002
296 SKIN WARM 1 0.0002
297 POST PROCEDURAL HAEMORRHAGE 2 0.0002
298 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
299 DECREASED INTEREST 1 0.0002
300 COVID-19 PNEUMONIA 2 0.0002
301 CATARACT OPERATION 1 0.0002
302 SINUS HEADACHE 1 0.0002
303 THIRST 3 0.0002
304 SYMPTOM RECURRENCE 1 0.0002
305 WRIST FRACTURE 2 0.0002
306 HEARING IMPAIRED 1 0.0002
307 BLOOD POTASSIUM DECREASED 5 0.0002
308 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
309 RASH PRURITIC 9 0.0002
310 SINUSITIS 17 0.0002
311 BURSITIS 2 0.0002
312 TENSION 1 0.0002
313 VULVOVAGINAL BURNING SENSATION 1 0.0002
314 MENISCUS INJURY 1 0.0002
315 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
316 PIGMENTATION DISORDER 1 0.0002
317 PRE-EXISTING CONDITION IMPROVED 1 0.0002
318 INFUSION SITE SWELLING 1 0.0002
319 PRODUCT COMPLAINT 4 0.0002
320 FEELING JITTERY 3 0.0002
321 INJECTION SITE IRRITATION 2 0.0002
322 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
323 ROTATOR CUFF SYNDROME 2 0.0002
324 INFUSION SITE PAIN 2 0.0002
325 CARDIAC FLUTTER 1 0.0002
326 INCOHERENT 1 0.0002
327 HIATUS HERNIA 2 0.0002
328 SKIN FISSURES 3 0.0002
329 POLYP 1 0.0002
330 SOMNAMBULISM 1 0.0002
331 DYSGRAPHIA 1 0.0002
332 DISABILITY 3 0.0002
333 OROPHARYNGEAL PAIN 14 0.0002
334 FUNGAL INFECTION 5 0.0001
335 QUALITY OF LIFE DECREASED 2 0.0001
336 PRODUCT ADMINISTRATION ERROR 3 0.0001
337 FEEDING DISORDER 3 0.0001
338 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
339 ABNORMAL LOSS OF WEIGHT 1 0.0001
340 NASOPHARYNGITIS 27 0.0001
341 BLOOD TESTOSTERONE DECREASED 1 0.0001
342 ONYCHOCLASIS 1 0.0001
343 RESPIRATION ABNORMAL 1 0.0001
344 JOINT EFFUSION 1 0.0001
345 HUNGER 2 0.0001
346 APHONIA 2 0.0001
347 CARPAL TUNNEL SYNDROME 2 0.0001
348 COUGH 40 0.0001
349 COVID-19 25 0.0001
350 PULMONARY TOXICITY 1 0.0001
351 HAND FRACTURE 1 0.0001
352 EATING DISORDER 3 0.0001
353 PRODUCT SUPPLY ISSUE 1 0.0001
354 IRRITABLE BOWEL SYNDROME 3 0.0001
355 IMPAIRED QUALITY OF LIFE 2 0.0001
356 ANOSMIA 2 0.0001
357 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
358 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
359 INTENTIONAL UNDERDOSE 1 0.0001
360 ORAL DISORDER 1 0.0001
361 MOUTH HAEMORRHAGE 1 0.0001
362 DYSURIA 5 0.0001
363 BLINDNESS TRANSIENT 1 0.0001
364 SKIN HAEMORRHAGE 2 0.0001
365 ARTHROPOD BITE 1 0.0001
366 PULMONARY MASS 2 0.0001
367 INFLUENZA LIKE ILLNESS 11 0.0001
368 HYPOAESTHESIA ORAL 2 0.0001
369 LACRIMATION INCREASED 4 0.0001
370 TENDON PAIN 1 0.0001
371 HEART RATE INCREASED 13 0.0001
372 NEPHROLITHIASIS 6 0.0001
373 DISSOCIATION 1 0.0001
374 PROCEDURAL COMPLICATION 1 0.0001
375 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
376 ANKLE FRACTURE 2 0.0001
377 PLASMA CELL MYELOMA 5 0.0001
378 CHEST DISCOMFORT 13 0.0001
379 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
380 NASAL DISCOMFORT 1 0.0001
381 CYSTITIS 4 0.0001
382 MOOD SWINGS 4 0.0001
383 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
384 FRUSTRATION TOLERANCE DECREASED 1 0.0001
385 NEURALGIA 3 0.0001
386 PSORIATIC ARTHROPATHY 5 0.0001
387 BACK DISORDER 2 0.0001
388 PRODUCT DOSE OMISSION 8 0.0001
389 POLYURIA 1 0.0001
390 HICCUPS 1 0.0001
391 HYPERAESTHESIA 1 0.0001
392 BRONCHITIS 9 0.0001
393 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
394 SPINAL COMPRESSION FRACTURE 1 0.0001
395 MENSTRUAL DISORDER 1 0.0001
396 LIP SWELLING 4 0.0001
397 GAIT INABILITY 4 0.0001
398 HAEMODIALYSIS 1 0.0001
399 SENSATION OF FOREIGN BODY 1 0.0001
400 INFUSION SITE ERYTHEMA 1 0.0001
401 CANDIDA INFECTION 2 0.0001
402 FLUID RETENTION 6 0.0001
403 VITAMIN D DECREASED 1 0.0001
404 PSEUDOMONAS INFECTION 1 0.0001
405 BLOOD MAGNESIUM DECREASED 1 0.0001
406 PSYCHOLOGICAL TRAUMA 1 0.0001
407 MUSCLE STRAIN 1 0.0001
408 HYSTERECTOMY 1 0.0001
409 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
410 NAIL DISORDER 1 0.0001
411 HEART RATE DECREASED 4 0.0001
412 DERMATITIS ATOPIC 6 0.0001
413 HEAD DISCOMFORT 2 0.0001
414 EAR INFECTION 3 0.0001
415 CARDIOTOXICITY 1 0.0001
416 MENSTRUATION IRREGULAR 3 0.0001
417 MYOSITIS 1 0.0001
418 ANAL INCONTINENCE 1 0.0001
419 DRY MOUTH 9 0.0001
420 TOOTHACHE 2 0.0001
421 LIMB INJURY 3 0.0001
422 LUPUS-LIKE SYNDROME 1 0.0001
423 PELVIC PAIN 2 0.0001
424 RESTLESS LEGS SYNDROME 2 0.0001
425 BONE DISORDER 2 0.0001
426 HIDRADENITIS 1 0.0001
427 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
428 RESTLESSNESS 4 0.0001
429 RETINAL DETACHMENT 1 0.0001
430 ABNORMAL DREAMS 3 0.0001
431 UROSEPSIS 1 0.0001
432 IRON DEFICIENCY ANAEMIA 1 0.0001
433 DIVERTICULITIS 3 0.0001
434 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
435 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
436 MENTAL STATUS CHANGES 3 0.0001
437 PRODUCT DISTRIBUTION ISSUE 1 0.0001
438 FEELING COLD 3 0.0001
439 NECK PAIN 6 0.0001
440 BACTERIAL INFECTION 2 0.0001
441 APPENDICITIS 1 0.0001
442 DEFORMITY 1 0.0001
443 EPISTAXIS 8 0.0001
444 ABDOMINAL PAIN UPPER 22 0.0001
445 EYE PAIN 6 0.0001
446 PHOTOPHOBIA 2 0.0001
447 HOT FLUSH 8 0.0001
448 BLOOD SODIUM DECREASED 2 0.0001
449 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
450 ARTHRALGIA 44 0.0001
451 PRODUCT PACKAGING ISSUE 1 0.0001
452 RED BLOOD CELL COUNT DECREASED 3 0.0001
453 MIGRAINE 10 0.0001
454 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
455 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
456 FATIGUE 81 0.0001
457 PERIPHERAL SWELLING 16 0.0001
458 SINUS BRADYCARDIA 1 0.0001
459 HERNIA 2 0.0001
460 DIZZINESS POSTURAL 1 0.0001
461 DYSPHONIA 6 0.0001
462 KIDNEY INFECTION 2 0.0001
463 MENORRHAGIA 2 0.0001
464 LABORATORY TEST ABNORMAL 3 0.0001
465 HOSPICE CARE 1 0.0001
466 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
467 HAEMATOCRIT DECREASED 2 0.0001
468 UPPER LIMB FRACTURE 2 0.0001
469 HYPOTONIA 1 0.0001
470 OVARIAN CYST 1 0.0001
471 SALIVARY HYPERSECRETION 1 0.0001
472 APHASIA 3 0.0001
473 FULL BLOOD COUNT DECREASED 2 0.0001
474 EYELID PTOSIS 1 0.0001
475 MUSCLE SPASMS 18 0.0001
476 LIMB DISCOMFORT 3 0.0001
477 TEMPERATURE INTOLERANCE 1 0.0001
478 SWOLLEN TONGUE 3 0.0001
479 ROAD TRAFFIC ACCIDENT 4 0.0001
480 TRANSFUSION 1 0.0001
481 ABDOMINAL DISCOMFORT 16 0.0001
482 SCRATCH 1 0.0001
483 OSTEOARTHRITIS 4 0.0001
484 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
485 RETCHING 2 0.0001
486 URINARY TRACT INFECTION 16 0.0001
487 IMPAIRED WORK ABILITY 2 0.0001
488 HEREDITARY ANGIOEDEMA 1 0.0001
489 HYPOACUSIS 4 0.0001
490 PHARYNGITIS STREPTOCOCCAL 1 0.0001
491 FAECES DISCOLOURED 2 0.0001
492 SKIN LACERATION 1 0.0001
493 BACK INJURY 1 0.0001
494 PRODUCT PRESCRIBING ISSUE 2 0.0001
495 PULMONARY THROMBOSIS 1 0.0001
496 CONSTIPATION 20 0.0001
497 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
498 OESOPHAGITIS 1 0.0001
499 IMPAIRED HEALING 3 0.0001
500 ASPIRATION 1 0.0001
501 EYE DISORDER 3 0.0001
502 GASTROINTESTINAL PAIN 1 0.0001
503 INJECTION SITE NODULE 1 0.0001
504 APPLICATION SITE PAIN 2 0.0001
505 THERAPEUTIC RESPONSE SHORTENED 3 0.0001
506 DENTAL CARIES 1 0.0001
507 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
508 SYNCOPE 9 0.0001
509 SKIN DISORDER 3 0.0001
510 GLOSSODYNIA 2 0.0001
511 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
512 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
513 THROAT IRRITATION 4 0.0001
514 ARTHRITIS 7 0.0001
515 BLOOD CALCIUM DECREASED 1 0.0001
516 HEART RATE IRREGULAR 2 0.0001
517 FLATULENCE 5 0.0001
518 PRODUCT SUBSTITUTION ISSUE 5 0.0001
519 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
520 CHILLS 10 0.0001
521 LYMPHADENOPATHY 3 0.0001
522 HEADACHE 53 0.0001
523 FEELING ABNORMAL 20 0.0001
524 LOCALISED INFECTION 2 0.0001
525 ADRENAL INSUFFICIENCY 1 0.0001
526 PANIC ATTACK 3 0.0001
527 DIARRHOEA 53 0.0001
528 BACK PAIN 19 0.0001
529 FEELING HOT 5 0.0001
530 INJECTION SITE URTICARIA 2 0.0001
531 SPINAL OPERATION 1 0.0001
532 TENDON RUPTURE 1 0.0001
533 PHARYNGITIS 1 0.0001
534 CYST 1 0.0001
535 SECRETION DISCHARGE 1 0.0001
536 MUSCLE ATROPHY 1 0.0001
537 INJECTION SITE SWELLING 6 0.0001
538 HYPOPHAGIA 2 0.0001
539 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
540 DECREASED APPETITE 18 0.0001
541 PLATELET COUNT INCREASED 1 0.0001
542 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
543 ABDOMINAL DISTENSION 8 0.0001
544 PSORIASIS 10 0.0001
545 SEDATION 2 0.0001
546 PARAESTHESIA 12 0.0001
547 JOINT STIFFNESS 2 0.0001
548 INFECTION 11 0.0001
549 IMMUNE SYSTEM DISORDER 1 0.0001
550 TOOTH INFECTION 1 0.0001
551 SARS-COV-2 TEST POSITIVE 1 0.0001
552 DEPRESSED MOOD 4 0.0001
553 DYSMENORRHOEA 1 0.0001
554 ADVERSE REACTION 1 0.0001
555 BLOOD PRESSURE DECREASED 5 0.0001
556 DRY SKIN 10 0.0001
557 PRODUCT DOSE OMISSION ISSUE 22 0.0001
558 SWELLING 7 0.0001
559 ASTHENIA 28 0.0001
560 PRODUCT TASTE ABNORMAL 1 0.0001
561 OEDEMA 4 0.0001
562 MOOD ALTERED 2 0.0001
563 SKIN LESION 2 0.0001
564 HAEMATOCHEZIA 4 0.0001
565 POLLAKIURIA 3 0.0001
566 INFLUENZA 8 0.0001
567 COORDINATION ABNORMAL 1 0.0001
568 WOUND 2 0.0001
569 MASS 1 0.0001
570 DYSPEPSIA 7 0.0001
571 DEVICE OCCLUSION 1 0.0001
572 DIALYSIS 1 0.0001
573 SINUS TACHYCARDIA 1 0.0001
574 HERPES ZOSTER 4 0.0001
575 SOMNOLENCE 14 0.0001
576 LETHARGY 4 0.0001
577 BALANCE DISORDER 6 0.0001
578 HYPERTHYROIDISM 1 0.0001
579 PALPITATIONS 8 0.0001
580 BONE PAIN 4 0.0001
581 SURGERY 4 0.0001
582 CARDIOMYOPATHY 1 0.0001
583 URINARY INCONTINENCE 2 0.0001
584 WHEEZING 4 0.0001
585 COLON CANCER 1 0.0001
586 IMMUNODEFICIENCY 1 0.0001
587 HAEMORRHAGE 7 0.0001
588 ANXIETY 19 0.0001
589 THERAPY NON-RESPONDER 3 0.0001
590 IRRITABILITY 4 0.0001
591 JOINT SWELLING 8 0.0001
592 ECONOMIC PROBLEM 1 0.0001
593 STOMATITIS 4 0.0001
594 OSTEOPENIA 1 0.0001
595 DISCOMFORT 4 0.0001
596 PHARYNGEAL OEDEMA 1 0.0001
597 TENDONITIS 1 0.0001
598 WEIGHT DECREASED 18 0.0001
599 BLOOD CHOLESTEROL INCREASED 3 0.0001
600 INSOMNIA 17 0.0001
601 PRODUCT USE COMPLAINT 1 0.0001
602 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
603 DYSPHAGIA 6 0.0001
604 HEAD INJURY 2 0.0001
605 FALL 21 0.0001
606 PNEUMOTHORAX 1 0.0001
607 ULCER 1 0.0001
608 PREMATURE DELIVERY 1 0.0001
609 PRURITUS 24 0.0001
610 SENSORY DISTURBANCE 1 0.0001
611 MOVEMENT DISORDER 2 0.0001
612 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
613 MUSCULAR WEAKNESS 7 0.0001
614 BLOOD POTASSIUM INCREASED 1 0.0001
615 NAUSEA 48 0.0001
616 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
617 HYPOAESTHESIA 9 0.0001
618 COAGULOPATHY 1 0.0001
619 DEHYDRATION 8 0.0001
620 EYE PRURITUS 2 0.0001
621 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
622 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
623 BLOOD PRESSURE INCREASED 9 0.0001
624 PAIN 36 0.0001
625 HAEMOGLOBIN DECREASED 6 0.0001
626 VISION BLURRED 8 0.0001
627 MUSCULOSKELETAL DISCOMFORT 1 0.0001
628 WEIGHT INCREASED 13 0.0001
629 DEVICE USE ERROR 2 0.0001
630 NEOPLASM PROGRESSION 2 0.0001
631 LOCAL SWELLING 1 0.0001
632 MUSCULOSKELETAL PAIN 3 0.0001
633 RASH MACULAR 2 0.0001
634 BURNING SENSATION 4 0.0001
635 CONDITION AGGRAVATED 17 0.0001
636 GASTROINTESTINAL DISORDER 5 0.0001
637 MOBILITY DECREASED 4 0.0001
638 SYNOVITIS 1 0.0001
639 CRYING 2 0.0001
640 TREATMENT NONCOMPLIANCE 3 0.0001
641 HYPERHIDROSIS 7 0.0001
642 ARTHROPATHY 3 0.0001
643 CONJUNCTIVITIS 1 0.0001
644 HEPATIC STEATOSIS 1 0.0001
645 THINKING ABNORMAL 1 0.0001
646 MIDDLE INSOMNIA 1 0.0001
647 OXYGEN SATURATION DECREASED 3 0.0001
648 HALLUCINATION 4 0.0001
649 UNEVALUABLE EVENT 4 0.0001
650 HYPOCALCAEMIA 1 0.0001
651 COLITIS 2 0.0001
652 DEPRESSION 12 0.0001
653 GASTRIC ULCER 1 0.0001
654 NEUROPATHY PERIPHERAL 5 0.0001
655 MUSCULOSKELETAL DISORDER 1 0.0001
656 INCREASED APPETITE 1 0.0001
657 GAIT DISTURBANCE 10 0.0001
658 EYE IRRITATION 3 0.0001
659 POST PROCEDURAL COMPLICATION 1 0.0001
660 SEROTONIN SYNDROME 1 0.0001
661 ACUTE RESPIRATORY FAILURE 1 0.0001
662 SEIZURE 6 0.0001
663 ERUCTATION 1 0.0001
664 HAEMORRHOIDS 1 0.0001
665 CHOKING 1 0.0001
666 ALOPECIA 10 0.0001
667 ABNORMAL BEHAVIOUR 2 0.0001
668 DISORIENTATION 2 0.0001
669 CATARACT 3 0.0001
670 BLOOD PRESSURE ABNORMAL 1 0.0001
671 INJECTION SITE BRUISING 4 0.0001
672 PRESCRIBED UNDERDOSE 1 0.0001
673 DIZZINESS 25 0.0001
674 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
675 THROMBOSIS 4 0.0000
676 PRODUCT PHYSICAL ISSUE 1 0.0000
677 DYSPNOEA 28 0.0000
678 PNEUMONIA 16 0.0000
679 PLEURAL EFFUSION 3 0.0000
680 PYREXIA 17 0.0000
681 INJURY ASSOCIATED WITH DEVICE 1 0.0000
682 VOMITING 23 0.0000
683 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
684 LUNG NEOPLASM MALIGNANT 2 0.0000
685 OSTEOPOROSIS 2 0.0000
686 INJECTION SITE WARMTH 1 0.0000
687 HYPERSENSITIVITY 9 0.0000
688 PRODUCT USE IN UNAPPROVED INDICATION 12 0.0000
689 TOOTH LOSS 1 0.0000
690 PULMONARY HYPERTENSION 1 0.0000
691 INTENTIONAL DRUG MISUSE 1 0.0000
692 WITHDRAWAL SYNDROME 2 0.0000
693 PAIN IN EXTREMITY 14 0.0000
694 SKIN EXFOLIATION 4 0.0000
695 HYPERTENSION 10 0.0000
696 MYALGIA 8 0.0000
697 JOINT INJURY 1 0.0000
698 POOR QUALITY SLEEP 1 0.0000
699 SKIN CANCER 1 0.0000
700 PRURITUS GENERALISED 1 0.0000
701 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
702 AMNESIA 3 0.0000
703 INTENTIONAL PRODUCT MISUSE 4 0.0000
704 INFUSION RELATED REACTION 3 0.0000
705 TOOTH DISORDER 1 0.0000
706 RASH MACULO-PAPULAR 1 0.0000
707 HYPOTENSION 9 0.0000
708 INJECTION SITE PRURITUS 3 0.0000
709 COLITIS ULCERATIVE 2 0.0000
710 PULMONARY OEDEMA 2 0.0000
711 CHROMATURIA 1 0.0000
712 INCORRECT DOSE ADMINISTERED 10 0.0000
713 MEMORY IMPAIRMENT 6 0.0000
714 RASH 19 0.0000
715 SKIN DISCOLOURATION 2 0.0000
716 MUSCLE TWITCHING 1 0.0000
717 MALAISE 19 0.0000
718 CONFUSIONAL STATE 7 0.0000
719 COGNITIVE DISORDER 2 0.0000
720 SLEEP DISORDER 3 0.0000
721 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
722 THERAPY INTERRUPTED 3 0.0000
723 ANAEMIA 8 0.0000
724 RASH ERYTHEMATOUS 2 0.0000
725 BLOOD PRESSURE FLUCTUATION 1 0.0000
726 DRUG INTOLERANCE 4 0.0000
727 MENTAL IMPAIRMENT 1 0.0000
728 PRESYNCOPE 1 0.0000
729 ABASIA 1 0.0000
730 INJECTION SITE ERYTHEMA 5 0.0000
731 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
732 INJECTION SITE PAIN 12 0.0000
733 HEPATITIS 1 0.0000
734 THERAPY CESSATION 2 0.0000
735 SKIN ULCER 1 0.0000
736 RASH GENERALISED 1 0.0000
737 EXPOSURE VIA SKIN CONTACT 1 0.0000
738 DIPLOPIA 1 0.0000
739 NERVOUSNESS 2 0.0000
740 DEAFNESS 1 0.0000
741 MUCOSAL INFLAMMATION 1 0.0000
742 APPLICATION SITE ERYTHEMA 1 0.0000
743 CHEST PAIN 7 0.0000
744 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
745 INJECTION SITE HAEMORRHAGE 3 0.0000
746 PLATELET COUNT DECREASED 4 0.0000
747 FEAR 1 0.0000
748 PAIN OF SKIN 1 0.0000
749 BLOOD BILIRUBIN INCREASED 1 0.0000
750 PALLOR 1 0.0000
751 PNEUMONITIS 1 0.0000
752 TREMOR 6 0.0000
753 PROCEDURAL PAIN 1 0.0000
754 URTICARIA 6 0.0000
755 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
756 PAIN IN JAW 1 0.0000
757 RHEUMATOID ARTHRITIS 4 0.0000
758 INTENTIONAL DOSE OMISSION 1 0.0000
759 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
760 HYPERSOMNIA 1 0.0000
761 LIVER FUNCTION TEST ABNORMAL 1 0.0000
762 NEEDLE ISSUE 1 0.0000
763 TACHYCARDIA 3 0.0000
764 RESPIRATORY DISORDER 1 0.0000
765 PREMATURE BABY 1 0.0000
766 THERAPEUTIC RESPONSE DECREASED 2 0.0000
767 ILL-DEFINED DISORDER 2 0.0000
768 OEDEMA PERIPHERAL 4 0.0000
769 VERTIGO 2 0.0000
770 INJECTION SITE RASH 1 0.0000
771 EMOTIONAL DISORDER 1 0.0000
772 VISUAL IMPAIRMENT 4 0.0000
773 PRODUCT USE ISSUE 6 0.0000
774 LOSS OF CONSCIOUSNESS 4 0.0000
775 CONTUSION 3 0.0000
776 HIP FRACTURE 1 0.0000
777 SWELLING FACE 2 0.0000
778 CHOLELITHIASIS 1 0.0000
779 STAPHYLOCOCCAL INFECTION 1 0.0000
780 DRUG DOSE OMISSION 5 0.0000
781 EXPIRED PRODUCT ADMINISTERED 1 0.0000
782 TYPE 2 DIABETES MELLITUS 1 0.0000
783 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
784 ANGER 1 0.0000
785 CEREBROVASCULAR ACCIDENT 5 0.0000
786 FLUSHING 3 0.0000
787 HAEMATURIA 1 0.0000
788 ERYTHEMA 6 0.0000
789 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
790 GASTRIC DISORDER 1 0.0000
791 NIGHTMARE 1 0.0000
792 DEVICE MALFUNCTION 2 0.0000
793 HYPOXIA 1 0.0000
794 CEREBRAL HAEMORRHAGE 1 0.0000
795 DRUG EFFECT INCOMPLETE 1 0.0000
796 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1 0.0000
797 C-REACTIVE PROTEIN INCREASED 1 0.0000
798 ACCIDENTAL OVERDOSE 1 0.0000
799 INJECTION SITE MASS 1 0.0000
800 DYSARTHRIA 1 0.0000
801 INTESTINAL OBSTRUCTION 1 0.0000
802 ACNE 2 0.0000
803 OFF LABEL USE 23 0.0000
804 DIABETES MELLITUS 2 0.0000
805 DRUG INEFFECTIVE 34 0.0000
806 CARDIAC FAILURE CONGESTIVE 2 0.0000
807 PROSTATE CANCER 2 0.0000
808 EMOTIONAL DISTRESS 3 0.0000
809 DEVICE BREAKAGE 1 0.0000
810 DYSKINESIA 1 0.0000
811 NEUTROPHIL COUNT DECREASED 1 0.0000
812 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
813 RENAL IMPAIRMENT 2 0.0000
814 VAGINAL HAEMORRHAGE 1 0.0000
815 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
816 MUSCULOSKELETAL STIFFNESS 2 0.0000
817 LIVER DISORDER 1 0.0000
818 DEVICE ISSUE 2 0.0000
819 ADVERSE DRUG REACTION 2 0.0000
820 PRODUCT QUALITY ISSUE 3 0.0000
821 NEUTROPENIA 3 0.0000
822 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
823 SUICIDAL IDEATION 2 0.0000
824 SKIN IRRITATION 1 0.0000
825 HYPOKALAEMIA 1 0.0000
826 ABDOMINAL PAIN 5 0.0000
827 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 1 0.0000
828 CARDIAC DISORDER 2 0.0000
829 ARRHYTHMIA 1 0.0000
830 OCULAR HYPERAEMIA 1 0.0000
831 MULTIPLE SCLEROSIS 1 0.0000
832 BLOOD GLUCOSE DECREASED 1 0.0000
833 HYPOGLYCAEMIA 1 0.0000
834 ATRIAL FIBRILLATION 2 0.0000
835 LUNG DISORDER 1 0.0000
836 LEUKOPENIA 1 0.0000
837 ACUTE KIDNEY INJURY 3 0.0000
838 HOSPITALISATION 3 0.0000
839 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
840 INFLAMMATION 1 0.0000
841 ECZEMA 1 0.0000
842 PANCREATITIS 1 0.0000
843 BRADYCARDIA 1 0.0000
844 DRUG EFFECT DECREASED 1 0.0000
845 DISTURBANCE IN ATTENTION 1 0.0000
846 BLISTER 1 0.0000
847 DISEASE PROGRESSION 2 0.0000
848 SUICIDE ATTEMPT 1 0.0000
849 EXPOSURE DURING PREGNANCY 1 0.0000
850 FEBRILE NEUTROPENIA 1 0.0000
851 RENAL FAILURE 2 0.0000
852 NEOPLASM MALIGNANT 1 0.0000
853 INJURY 1 0.0000
854 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
855 DEATH 12 0.0000
856 UNDERDOSE 1 0.0000
857 DRUG INTERACTION 2 0.0000
858 CARDIAC FAILURE 1 0.0000
859 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
860 CARDIAC ARREST 1 0.0000
861 DRUG ABUSE 1 0.0000
862 MYOCARDIAL INFARCTION 2 0.0000
863 BLOOD GLUCOSE INCREASED 2 0.0000
864 PULMONARY EMBOLISM 1 0.0000
865 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
866 SEPSIS 1 0.0000
867 ASTHMA 1 0.0000
868 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
869 TOXICITY TO VARIOUS AGENTS 1 0.0000
870 NO ADVERSE EVENT 1 0.0000